Partnership Opportunities
Our goal is to create partnerships with companies to help minimize their investment risk by providing the research environment, expertise, clinical samples and joint funding to conduct the preclinical and early-stage clinical research necessary to find treatments that would otherwise be ignored in the traditional for-profit, drug-development process. We see this as a revolutionary business model that will accelerate access to treatment for pediatric patients.
Potential partnerships are available in these areas:
Therapeutics
- ADHD
- Allergy and Asthma – Mast Cells
- Asthma
- Bone Disorders and Malformations
- Brain Malformations
- Brain Tumors – Combination Therapies
- Cancer, Inherited, and Infectious Disease – Cell Transduction
- Cancer – Advancing Immunotherapy
- Cancer – Drugs for Sarcoma
- Cancer – Improved CAR T Targeting
- Cancer – Mouse Model for CAR-T Therapy
- Cancer – Neuroblastoma
- Cancer – Neurotoxicity
- Cancer – Small Molecules for CAR T
- Cancer – T cell conditioning
- Cancer – Target Validation
- Cell and Gene Therapies
- Cerebellar Development
- Chronic Pain
- Concussion
- Congenital Disorders – Genetic Testing
- Congenital Disorders of Glycosylation
- Congenital Heart Defects – Zebrafish Models
- COVID-19 and Other Viral Diseases
- Craniofacial Malformations – Clinical Data
- Cryptosporidium and Other Parasites
- Dravet – Advanced Model
- Duchenne Muscular Dystrophy – Zebrafish Models
- Epilepsy – Stem Cell Models
- Fibrosis
- Group B Streptococcus
- Heart Arrhythmia
- Heart Metabolism and Function
- Heart Surgery – “Ductal Paint”
- Heart Transplant – Eplet Mismatches
- Heart Transplant – Extracorporeal Photophoresis
- Heart Transplant – Immunoreactivity and Tolerance
- Hemophilia – Immunomodulation Therapy
- Hemophilia – Intraosseous Lentiviral Therapy
- HIV Microbiomes
- HIV – CAR-T therapies
- HIV – Diagnostics
- HIV – Viral Reservoirs
- HIV – Transmission and Progression
- Hypoplastic Left Heart Syndrome
- Infantile Hemangiomas and Other Vascular Malformations
- Infectious Diseases – Immune Development
- Infectious and Neurodegenerative Diseases: Interactomes
- Inflammatory Bowel Disease – Dietary Modifications
- Influenza – Vaccines
- Kawasaki Disease
- Lupus – B-Cell Integrins
- Lupus – B-Cell Targets
- Malaria – Dormant Liver Form
- Malaria – Host-Pathogen Interactions
- Malaria – Human Immune Response
- Malaria – Molecular Mechanisms
- Malaria – Next-Generation Therapeutics
- Malaria – Vaccines, Therapies, Drug Resistance
- Malaria and HIV – Monoclonal Antibodies
- Mitochondrial Diseases – Identifying Therapies
- Motor Impairments and Paralysis
- Nanobodies – Diagnostic and Therapeutic Resources
- Neural Development and Neurodegeneration
- Nontuberculous Mycobacterial Diseases – Drug Discovery
- Obesity – Chimeric Peptide Therapeutics
- Opioid Sensitivity and Tolerance
- Optimizing CAR T Cells at the Level of Receptor Signaling
- Pain
- Peroxisomal Disorders
- Retinal Disorders
- Rheumatic Diseases
- Stroke – Neurovascular Imaging
- Trypanosomal Diseases
- Tuberculosis
- Tuberculosis – Drug Discovery
- Tuberculosis – Drug Regimens
- Tuberculosis – Phosphosignaling Pathways
- Tuberculosis and Nontuberculosis Mycobacterial Diseases
- Vascular and Lymphatic Malformations – Genotyping and Treatment
- Wilson Disease and Other Lysosomal Storage Diseases – Newborn Screening
Diagnostics
- Autism and Fragile X Syndrome — Signal Transduction and Therapeutics
- Cancer – Macrophage Regulation
- Cancer – Neuroblastoma
- Cancer – Neurotoxicity
- Concussion
- Congenital Disorders – Genetic Testing
- Healthcare Associated Infections
- Heart Transplant – Eplet Mismatches
- Heart Transplant – Immunoreactivity and Tolerance
- HIV – Diagnostics
- HIV – Viral Reservoirs
- Human Herpesvirus HHV-6 – Epidemiology
- Infantile Hemangiomas and Other Vascular Malformations
- Kawasaki Disease
- Juvenile Idiopathic Arthritis
- Lupus – B-Cell Targets
- Nanobodies – Diagnostic and Therapeutic Resources
- Retinal Disorders
- Sepsis
- Sleep Apnea
- Tuberculosis and Antimicrobial-Resistance
- Vascular and Lymphatic Malformations – Genotyping and Treatment
- Wilson Disease and Other Lysosomal Storage Diseases – Newborn Screening
Medical Devices
- Craniofacial Malformations – Clinical Data
- Epilepsy – Medical Device Interventions
- Heart Arrhythmia
- Hemophilia – Gene Therapy
- Hypoplastic Left Heart Syndrome
- Juvenile Idiopathic Arthritis
- Malaria – Insect Dissection Tool
- Motor Impairments and Paralysis
- Sleep Apnea
Vaccines
- COVID-19 and Other Viral Diseases
- Group B Streptococcus
- HIV – Transmission and Progression
- Infectious Diseases – Immune Development
- Influenza – Vaccines
- Malaria – Dormant Liver Form
- Malaria – Human Immune Response
- Malaria – P. falciparum and P. vivax
- Malaria – Vaccines, Therapies, Drug Resistance
- Malaria and HIV – Monoclonal Antibodies
- Tuberculosis
- Tuberculosis and Nontuberculous Mycobacterial Diseases
Research Tools and Understanding Disease Pathways
- Addiction – Characterizing Pathways
- Allergy and Asthma – Mast Cells
- Anesthesia Risks
- Autism and Fragile X Syndrome — Signal Transduction and Therapeutics
- Asthma
- Bone Disorders and Malformations
- Brain Overgrowth Diseases
- Brain Malformations
- Brain Tumors – Combination Therapies
- Brain Tumors – Neurotrophin Receptors
- Breathing Dysregulation
- Cancer, Inherited, and Infectious Disease – Cell Transduction
- Cancer – Improved CAR T Targeting
- Cancer – Mouse Model for CAR-T Therapy
- Cancer – Neuroblastoma
- Cancer – Neurotoxicity
- Cancer – Small Molecules for CAR T
- Cancer – Target Validation
- Cell and Gene Therapies
- Cerebellar Development
- Congenital Disorders – Genetic Testing
- Congenital Disorders of Glycosylation
- Congenital Heart Defects – Zebrafish Models
- Cryptosporidium and Other Parasites
- Dravet – Advanced Model
- Duchenne Muscular Dystrophy – Zebrafish Models
- Epilepsy – Stem Cell Models
- Fibrosis
- Food Insecurity and Chronic Disease Management
- Healthcare Associated Infections
- Heart Metabolism and Function
- Heart Surgery – “Ductal Paint”
- Heart Transplant – Eplet Mismatches
- Heart Transplant – Extracorporeal Photophoresis
- Heart Transplant – Immunoreactivity and Tolerance
- HIV and Other Infectious Diseases – B-cell Sequencing
- HIV Microbiomes
- HIV – Transmission and Progression
- HIV – Viral Reservoirs
- Human Herpesvirus HHV-6 – Epidemiology
- Hypoplastic Left Heart Syndrome
- Infectious Diseases – Immune Development
- Infectious and Neurodegenerative Diseases: Interactomes
- Influenza – Vaccines
- Juvenile Idiopathic Arthritis
- Lupus – B-Cell Integrins
- Lupus – B-Cell Targets
- Malaria – Dormant Liver Form
- Malaria – Host Pathogen Interactions
- Malaria – Human Immune Response
- Malaria – Insect Dissection Tool
- Malaria – Molecular Mechanisms
- Malaria – P. falciparum and P. vivax
- Malaria – Vaccines, Therapies, Drug Resistance
- Malaria and HIV – Monoclonal Antibodies
- Mitochondrial Disease
- Mitochondrial Diseases – Identifying Therapies
- MRSA Infections
- Neural Development and Neurodegeneration
- Nontuberculous Mycobacterial Diseases – Drug Discovery
- Obesity – Chimeric Peptide Therapeutics
- Opioid Sensitivity and Tolerance
- Optimizing CAR T Cells at the Level of Receptor Signaling
- Organ Development
- Peroxisomal Disorders
- Retinal Disorders
- Rheumatic Diseases
- Sepsis
- Sleep Apnea
- Stroke
- Stroke – Neurovascular Imaging
- Trypanosomal Diseases
- Tuberculosis
- Tuberculosis – Drug Discovery
- Tuberculosis – Drug Regimens
- Tuberculosis – Phosphosignaling Pathways
- Tuberculosis and Antimicrobial-Resistance
- Vascular and Lymphatic Malformations – Genotyping and Treatment
- Viral Diseases – Improving RNA-Seq
- Wilson Disease and Other Lysosomal Storage Diseases – Newborn Screening
Educational Products and Digital Health
- Activity and Fitness
- Activity Trackers and Apps
- ADHD
- Adolescent-Focused Digital Health Interventions
- Inflammatory Bowel Disease – Dietary Modifications
- Pain
Learn More
To learn more about partnering with Seattle Children’s Research Institute, or if you’re a Seattle Children’s researcher looking for industry partners, please email the Office of Science-Industry Partnerships.
Contact Us
Physical Address
818 Stewart St.
Seattle, WA 98101
Mailing Address
M/S 818-S
PO Box 5371
Seattle, WA 98145-5005
